Rachelle Suzanne Jacques's Net Worth
$3.76 Billion
Who is Rachelle Suzanne Jacques?
Rachelle Suzanne Jacques has an estimated net worth of $3.76 Billion. This is based on reported shares across multiple companies, which include uniQure N.V., Viela Bio, Inc., Corbus Pharmaceuticals Holdings, Inc., and Akari Therapeutics Plc.
SEC CIK
Rachelle Suzanne Jacques's CIK is 0001772610
Past Insider Trading and Trends
2022 was Rachelle Suzanne Jacques's most active year for acquiring shares with 5 total transactions. Rachelle Suzanne Jacques's most active month to acquire stocks was the month of May. 2021 was Rachelle Suzanne Jacques's most active year for disposing of shares, totalling 2 transactions. Rachelle Suzanne Jacques's most active month to dispose stocks was the month of February. 2024 saw Rachelle Suzanne Jacques paying a total of $0.00 for 479,599,378 shares, this is the most they've acquired in one year. In 2023 Rachelle Suzanne Jacques cashed out on 2,685 shares for a total of $50,854.44, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
uniQure N.V. (QURE) Snapshot price: $5.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56.08% | 8.08K |
—
|
—
| 22.49K |
Jun 19
| |||
Form 4
| -13.36% | -2.22K |
$5.14 | -$11,415.94 | 14.41K |
Jun 13
| |||
Form 4
| +62.55% | 6.4K |
$18.76 | -$43,166.76 | 16.63K |
Jun 13 - Jun 16
| |||
Form 4
| -3.62% | -384.00 |
$20.02 | -$7,687.68 | 10.23K |
Feb 27
| |||
Form 4
| +591.92% | 9.08K |
—
|
—
| 10.61K |
Jun 15
| |||
Form 4
|
∞
| 1.53K |
—
|
—
| 1.53K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viela Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.78K |
—
|
—
| 2.78K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akari Therapeutics Plc (AKTX) Snapshot price: $3.69
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +89.06% | 479.57M |
—
|
—
| 1.02B |
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||